Although tumour hypoxia is strongly associated with cancer progression and resistance to therapy, we cannot conclude whether in SPN mutation or reduced expression of KDM6A is an epiphenomenon of oxygen shortage or instead precedes the formation of a hypoxic microenvironment. This evidence concerns the gene KDM6A and cancer.